Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karen McLachlan

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|February 25, 2015
Correction: novel insights on human NK cells' immunological modalities revealed by gene expression profilingJacob Hanna, Pamela Bechtel, Yufeng Zhai, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 24, 2004
Novel insights on human NK cells' immunological modalities revealed by gene expression profilingJacob Hanna, Pamela Bechtel, Yufeng Zhai, et al.
Acta Paediatrica (Oslo, Norway : 1992)|July 11, 2006
Thyroxine: cause and cure for headacheM Guftar Shaikh, Nalin Wickramasuriya, Karen McLachlan, et al.
Insects|August 25, 2022
New Canadian and Provincial Records of Coleoptera Resulting from Annual Canadian Food Inspection Agency Surveillance for Detection of Non-Native, Potentially Invasive Forest InsectsGraham S Thurston, Alison Slater, Inna Nei, et al.
Archives of Disease in Childhood|March 31, 2017
Pseudotumor cerebri syndrome in childhood: incidence, clinical profile and risk factors in a national prospective population-based cohort studyYim-Yee Matthews, Fiona Dean, Ming J Lim, et al.
Cell Communication & Adhesion|November 4, 2008
Functional characterization of integrin alpha6beta4 adhesion interactions using soluble integrin constructs reveals the involvement of different functional domains in the beta4 subunitLing Ling Chen, Veronica Gabarra, Samuel Cho, et al.
Cancer Biology & Therapy|January 12, 2010
Antibodies directed to alpha6beta4 highlight the adhesive and signaling functions of the integrin in breast cancer cell linesVeronica Gabarra, Samuel Cho, Miriam Ramirez, et al.
JCO Precision Oncology|July 9, 2025
LODESTAR: A Single-Arm Phase II Study of Rucaparib in Solid Tumors With Pathogenic Germline or Somatic Variants in Homologous Recombination Repair GenesSriram Anbil, Nicholas J Seewald, E Gabriela Chiorean, et al.
The Lancet. Oncology|February 6, 2025
Rucaparib versus chemotherapy for treatment of relapsed ovarian cancer with deleterious BRCA1 or BRCA2 mutation (ARIEL4): final results of an international, open-label, randomised, phase 3 trialAmit M Oza, Alla Lisyanskaya, Alexander Fedenko, et al.
The Lancet. Oncology|March 17, 2022
Rucaparib versus standard-of-care chemotherapy in patients with relapsed ovarian cancer and a deleterious BRCA1 or BRCA2 mutation (ARIEL4): an international, open-label, randomised, phase 3 trialRebecca Kristeleit, Alla Lisyanskaya, Alexander Fedenko, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Journal of Immunology (Baltimore, Md. : 1950)|February 25, 2015
Correction: novel insights on human NK cells' immunological modalities revealed by gene expression profilingJacob Hanna, Pamela Bechtel, Yufeng Zhai, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 24, 2004
Novel insights on human NK cells' immunological modalities revealed by gene expression profilingJacob Hanna, Pamela Bechtel, Yufeng Zhai, et al.
Acta Paediatrica (Oslo, Norway : 1992)|July 11, 2006
Thyroxine: cause and cure for headacheM Guftar Shaikh, Nalin Wickramasuriya, Karen McLachlan, et al.
Insects|August 25, 2022
New Canadian and Provincial Records of Coleoptera Resulting from Annual Canadian Food Inspection Agency Surveillance for Detection of Non-Native, Potentially Invasive Forest InsectsGraham S Thurston, Alison Slater, Inna Nei, et al.
Archives of Disease in Childhood|March 31, 2017
Pseudotumor cerebri syndrome in childhood: incidence, clinical profile and risk factors in a national prospective population-based cohort studyYim-Yee Matthews, Fiona Dean, Ming J Lim, et al.
Cell Communication & Adhesion|November 4, 2008
Functional characterization of integrin alpha6beta4 adhesion interactions using soluble integrin constructs reveals the involvement of different functional domains in the beta4 subunitLing Ling Chen, Veronica Gabarra, Samuel Cho, et al.
Cancer Biology & Therapy|January 12, 2010
Antibodies directed to alpha6beta4 highlight the adhesive and signaling functions of the integrin in breast cancer cell linesVeronica Gabarra, Samuel Cho, Miriam Ramirez, et al.
JCO Precision Oncology|July 9, 2025
LODESTAR: A Single-Arm Phase II Study of Rucaparib in Solid Tumors With Pathogenic Germline or Somatic Variants in Homologous Recombination Repair GenesSriram Anbil, Nicholas J Seewald, E Gabriela Chiorean, et al.
The Lancet. Oncology|February 6, 2025
Rucaparib versus chemotherapy for treatment of relapsed ovarian cancer with deleterious BRCA1 or BRCA2 mutation (ARIEL4): final results of an international, open-label, randomised, phase 3 trialAmit M Oza, Alla Lisyanskaya, Alexander Fedenko, et al.
The Lancet. Oncology|March 17, 2022
Rucaparib versus standard-of-care chemotherapy in patients with relapsed ovarian cancer and a deleterious BRCA1 or BRCA2 mutation (ARIEL4): an international, open-label, randomised, phase 3 trialRebecca Kristeleit, Alla Lisyanskaya, Alexander Fedenko, et al.
Pageof 1